세계의 바이오 분석 검사 서비스 시장 : 시장 규모, 점유율, 동향 분석 - 분자별, 검사별, 워크플로우별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Molecule (Small, Large), By Test (ADME, PD), By Workflow, By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,242,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,627,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,398,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

바이오 분석 검사 서비스 시장의 성장 및 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 바이오 분석 검사 서비스 시장 규모는 2030년까지 80억 2,000만 달러에 이를 것으로 예측되며, 2025-2030년 CAGR 9.21%로 성장할 것으로 예측됩니다.

핵심 역량을 효율화하기 위해 여러 바이오 의약품 기업이 연구개발 활동을 아웃소싱하는 비율이 증가하고 있는 것이 시장 성장을 뒷받침하는 주요 요인 중 하나입니다. 또한 SARS-CoV-2 감염 사례의 급증으로 세계 코로나19 백신의 대량생산이 대폭 생산됨에 따라 코로나19 발생이 의약품 분석 시범서비스의 수요를 더욱 끌어올리고 있습니다.

게다가 세계에서 의약품 수요가 증가하고 있기 때문에 시장 개척을 위해 생물 분석 검사를 필요로 하는 파이프라인 의약품이 급증하고 시장의 성장을 증대시키고 있습니다. 게다가 전 세계적으로 개발 능력을 확대하는 수탁 제조 기업이 증가하고 있기 때문에 예측 기간 동안 시장은 상당한 성장을 이룰 것으로 예상됩니다. 예를 들어, 2023년 9월, Cerba HealthCare사는 생물 분석 능력을 확대하고 복잡한 임상시험 실시에 필요한 시간을 단축하기 위해 캐나다 수탁연구기관인 CIRION BioPharma Research사 인수를 발표했습니다.

제품의 품질, 환경 문제, 소비자 안전에 대한 의식의 고조는 자사 제품이 전술의 측면에 적합하고 있는 것을 보증하는 수단으로서, 기업이 시험을 외주하는 것을 뒷받침하고 있습니다. 이것은 브랜드 이미지의 구축이나 평판의 보호 및 향상에 도움이 되고 있습니다. 미국 FDA는 바이오 분석 검사 및 관련 규제에 관한 인식을 높이기 위한 워크숍을 실시하고 있습니다.

주요 사업회사는 시장에서의 존재감을 높이기 위해 다양한 전략적 이니셔티브를 실시했습니다. 예를 들어 2023년 8월 Pace Analytical Services는 Alpha Analytical 인수를 발표하고 퇴적물 및 조직 검사 확대와 함께 고도의 탄화수소 분석 지원 등의 새로운 기능을 추가했습니다. 게다가 2022년 4월, Charles River Laboratories는, 위탁 연구 서비스의 저명한 기업인 Explora BioLabs를 현금 2억 9,500만 달러에 인수했습니다. 이로써 이 회사는 이 시장에서의 사업 능력을 확대했습니다.

바이오 분석 검사 서비스 시장 보고서 하이라이트

• 2024년 매출액 점유율은 저분자 분야가 55.3% 이상으로 최대였습니다. 제네릭 의약품 개발 수요의 높은 수준이 부문 성장을 뒷받침했습니다.
• 고분자 부문은 예측 기간 중에 가장 빠른 CAGR이 예상됩니다. 이것은 바이오 의약품 개발에 대한 투자와 집중이 증가하고 있기 때문입니다.
• 생물학적 동등성 부문은 예측 기간 동안 가장 빠른 CAGR을 나타낼 것으로 예측됩니다. 이는 제네릭 의약품과 바이오시밀러의 생산 및 소비 증가에 기인하고 있습니다.
• 시료 준비 부문은 2024년에 큰 시장 점유율을 차지했으며, 2025-2030년 가장 빠른 CAGR로 더욱 확대될 것으로 추정됩니다.
• 북미는 미국에서 여러 제약 기업의 강력한 존재로 인해 2024년 가장 규모가 큰 지역 시장이 되었습니다.
• 한편, 아시아태평양 시장은 제약 및 바이오테크놀러지 활동 증가, 의료 지출 증가로 2025-2030년 가장 빠른 CAGR을 나타낼 것으로 예측됩니다.

목차

제1장 분석 방법 및 범위

제2장 주요 요약

제3장 시장의 변동 요인, 경향 및 범위

• 시장 연관 전망
  • 상위 시장 전망
  • 관련 및 부수 시장 전망
• 시장 동향 및 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 투자 및 자금 조달의 관점
• 임상시험 건수 분석(2024년)
  • 임상시험 총수 : 지역별(2024년)
  • 임상시험 총수 : 상별(2024년)
  • 임상시험 총수 : 연구 디자인별(2024년)
  • 임상시험 총수 : 주요 치료 영역별(2024년)
• 기술 상황
• 가격 모델 분석
• 업계 분석 툴
  • Porter's Five Forces 분석
  • PESTEL 분석
  • COVID-19의 영향 분석

제4장 바이오 분석 검사 서비스 시장 : 분자별 추정 및 동향 분석

• 부문 대시보드
• 바이오 분석 검사 서비스 시장 : 분자별 변동 분석
• 바이오 분석 검사 서비스 시장 : 분자별 시장 및 동향 분석(2018-2030년)
• 저분자
• 고분자
  • LC-MS 연구
  • 면역 측정
  • 기타 고분자 시험

제5장 바이오 분석 검사 서비스 시장 : 검사별 추정 및 동향 분석

• 부문 대시보드
• 바이오 분석 검사 서비스 시장 : 검사별 변동 분석
• 바이오 분석 검사 서비스 시장 : 검사별 시장 및 동향 분석(2018-2030년)
• ADME
• 약동학(PK)
• 약역학(PD)
• 바이오 가용성
• 생물적 동등성
• 바이오마커 검사
• 세포 기반 분석
• 바이러스 검사
• 기타 검사

제6장 바이오 분석 검사 서비스 시장 : 워크플로우별 추정 및 동향 분석

• 부문 대시보드
• 바이오 분석 검사 서비스 시장 : 워크플로우별 변동 분석
• 바이오 분석 검사 서비스 시장 : 워크플로우별 시장 및 동향 분석(2018-2030년)
• 시료의 수집 및 조제
  • 시료의 수집, 핸들링 및 보관
  • 단백질 침전
  • 액액 추출
  • 고상 추출
  • 기타
• 방법 개발 및 검증
• 시료 분석
  • 하이픈 기법
  • 크로마토그래피 기술
  • 전기영동
  • 리간드 결합 분석
  • 질량 분석
  • 분광기술
  • 유전체 및 분자 기술
• 기타 프로세스

제7장 바이오 분석 검사 서비스 시장 : 최종 용도별 추정 및 동향 분석

• 부문 대시보드
• 바이오 분석 검사 서비스 시장 : 최종 용도별 변동 분석
• 바이오 분석 검사 서비스 시장 : 최종 용도별 시장 및 동향 분석(2018-2030년)
• 제약 및 바이오 의약품 기업
• CDMO
• CRO(의약품 개발 업무 수탁 기관)
• 기타

제8장 지역별 비즈니스 분석

• 지역별 대시보드
• 시장 규모 예측 및 동향 분석(2018-2030년)
• 북미
  • 북미의 바이오 분석 검사 서비스 시장 : 추계 및 예측(2018-2030년)
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 유럽의 바이오 분석 검사 서비스 시장 : 추계 및 예측(2018-2030년)
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 네덜란드
  • 스위스
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 아시아태평양의 바이오 분석 검사 서비스 시장 : 추계 및 예측(2018-2030년)
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 말레이시아
  • 싱가포르
  • 대만
• 라틴아메리카
  • 라틴아메리카의 바이오 분석 검사 서비스 시장 : 추계 및 예측(2018-2030년)
  • 브라질
  • 아르헨티나
  • 콜롬비아
• 중동 및 아프리카
  • 중동 및 아프리카의 바이오 분석 검사 서비스 시장 : 추계 및 예측(2018-2030년)
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제9장 경쟁 구도

• 기업 분류
• 기업시장 포지셔닝 분석(2024년)
• 기업 프로파일
  • Thermo Fisher Scientific Inc
  • ICON Plc
  • Charles River Laboratories International
  • IQVIA Inc.
  • Syneos Health
  • SGS SA
  • Labcorp
  • Intertek Group Plc
  • Pace Analytical Services LLC
  • Wuxi AppTec

AJY

영문 목차

영문목차

Bioanalytical Testing Services Market Growth & Trends:

The global bioanalytical testing services market size is anticipated to reach USD 8.02 billion by 2030 and is projected to grow at a CAGR of 9.21% from 2025 to 2030, according to a new report by Grand View Research, Inc. An increasing rate of outsourcing R&D activities by several biopharmaceutical companies to streamline their core competencies is one of the major factors supporting the market growth. In addition, the outbreak of COVID-19 has further boosted demand for pharma-analytical testing services as the rapid surge in SARS-CoV-2 infection cases has significantly augmented the production of a larger batch of COVID-19 vaccines across the globe.

Furthermore, the growing demand for pharmaceutical products across the globe has resulted in a surge of pipeline drugs that require bioanalytical testing for development, thus augmenting the market growth. In addition, the market is expected to witness considerable growth over the forecast period owing to an increasing number of contract manufacturing companies expanding their development capacities across the globe. For instance, in September 2023, Cerba HealthCare announced the acquisition of CIRION BioPharma Research, a Canadian contract research laboratory, to expand its bioanalytical capabilities and reduce the time required for implementing intricate clinical trials.

Increasing awareness about product quality, environmental issues, and the safety of consumers are driving companies to outsource tests as a means to ensure that their products comply with the aforementioned aspects. This helps them build brand image and protects as well as enhances reputation. The U.S. FDA has conducted workshops to increase awareness regarding bioanalytical testing and related regulations.

Key operating companies are undertaking various strategic initiatives to strengthen their market presence. For instance, in August 2023, Pace Analytical Services announced the acquisition of Alpha Analytical, adding new capabilities such as advanced hydrocarbon analytical support along with expanded sediment & tissue testing. Moreover, in April 2022, Charles River Laboratories acquired Explora BioLabs, a prominent player in contract research services, for USD 295 million in cash. This has broadened the company's operating capabilities in the market.

Bioanalytical Testing Services Market Report Highlights:

• Small molecule segment accounted for the largest revenue share of over 55.3% in 2024. The high demand for generic drug development boosts the segment growth
• Large molecule segment is anticipated to witness fastest CAGR during the forecast period. This is attributed to the increased investment and focus on the development of biopharmaceuticals
• The bioequivalence segment is estimated to witness the fastest CAGR during the forecast period. This is attributed to the growing production and consumption of generics & biosimilars
• The sample preparation segment held a significant market share in 2024 and is estimated to expand further at the fastest CAGR from 2025 to 2030
• North America was the largest regional market in 2024 due to the strong presence of several pharmaceutical players in the U.S.
• On the other hand, the market in Asia Pacific is projected to register the fastest CAGR from 2025 to 2030 owing to increasing pharmaceutical & biotechnology activities, rising healthcare expenditure

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Information Analysis
  • 1.4.2. Market Formulation & Data Visualization
  • 1.4.3. Data Validation & Publishing
• 1.5. Model Details
  • 1.5.1. Commodity Flow Analysis (Model 1)
  • 1.5.2. Top Down Market Estimation (Model 2)
  • 1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
  • 1.5.4. Multivariate Analysis (Model 4)
• 1.6. List of Secondary Sources
• 1.7. List of Abbreviations
• 1.8. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
  • 3.3.2. Market Restraint Analysis
• 3.4. Investments & Funding Perspective
• 3.5. Clinical Trials Volume Analysis, (2024)
  • 3.5.1. Total Number of Clinical Trials, by Region (2024)
  • 3.5.2. Total Number of Clinical Trials, by Phase (2024)
  • 3.5.3. Total Number of Clinical Trials, by Study Design (2024)
  • 3.5.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
• 3.6. Technology Landscape
• 3.7. Pricing Model Analysis
• 3.8. Industry Analysis Tools
  • 3.8.1. Porter's Five Forces Analysis
  • 3.8.2. PESTEL Analysis
  • 3.8.3. COVID-19 Impact Analysis

Chapter 4. Bioanalytical Testing Services Market: Molecule Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Bioanalytical Testing Services Market; Molecule Movement Analysis
• 4.3. Bioanalytical Testing Services Size & Trend Analysis, by Molecule, 2018 to 2030 (USD Million)
• 4.4. Small Molecule
  • 4.4.1. Small molecule market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Large Molecule
  • 4.5.1. Large molecule market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. LC-MS studies
    • 4.5.2.1. LC-MS studies market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Immunoassays
    • 4.5.3.1. Immunoassays market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3.2. Pharmacokinetics (PK)
      • 4.5.3.2.1. Pharmacokinetics (PK) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3.3. ADA assay
      • 4.5.3.3.1. ADA assay market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3.4. Other
      • 4.5.3.4.1. Other large molecule tests market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.4. Other large molecule tests
    • 4.5.4.1. Other large molecule tests market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Bioanalytical Testing Services Market: Test Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Bioanalytical Testing Services Market; Test Movement Analysis
• 5.3. Bioanalytical Testing Services Size & Trend Analysis, by Test, 2018 to 2030 (USD Million)
• 5.4. ADME
  • 5.4.1. ADME market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Pharmacokinetics (PK)
  • 5.5.1. Pharmacokinetics (PK) market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Pharmacodynamics (PD)
  • 5.6.1. Pharmacodynamics (PD) market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Bioavailability
  • 5.7.1. Bioavailability market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Bioequivalence
  • 5.8.1. Bioequivalence market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Biomarker testing
  • 5.9.1. Biomarker testing market estimates and forecasts 2018 to 2030 (USD Million)
• 5.10. Cell-based assay
  • 5.10.1. Cell-based assay market estimates and forecasts 2018 to 2030 (USD Million)
• 5.11. Virology testing
  • 5.11.1. Virology testing market estimates and forecasts 2018 to 2030 (USD Million)
• 5.12. Other tests
  • 5.12.1. Other tests market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Bioanalytical Testing Services Market: Workflow Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Bioanalytical Testing Services Market; Workflow Movement Analysis
• 6.3. Bioanalytical Testing Services Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
• 6.4. Sample Collection and Preparation
  • 6.4.1. Sample collection and preparation market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Sample collection, handling and storage
    • 6.4.2.1. Sample collection, handling and storage market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Protein precipitation
    • 6.4.3.1. Protein precipitation market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Liquid-Liquid extraction
    • 6.4.4.1. Liquid-Liquid extraction market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Solid Phase extraction
    • 6.4.5.1. Solid phase extraction market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Others
    • 6.4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Method Development and Validation
  • 6.5.1. Method development and validation market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Sample analysis
  • 6.6.1. Sample analysis market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Hyphenated technique
    • 6.6.2.1. Hyphenated technique market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. Chromatographic technique
    • 6.6.3.1. Chromatographic technique market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Electrophoresis
    • 6.6.4.1. Electrophoresis market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Ligand binding assay
    • 6.6.5.1. Ligand binding assay market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Mass spectrometry
    • 6.6.6.1. Mass spectrometry market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.7. Spectroscopic techniques
    • 6.6.7.1. Spectroscopic techniques market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7.2. Nuclear Magnetic Resonance (NMR)
      • 6.6.7.2.1. Nuclear Magnetic Resonance (NMR) market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7.3. Others
      • 6.6.7.3.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.8. Genomic and Molecular Techniques
    • 6.6.8.1. Genomic and molecular techniques market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8.2. Polymerase Chain Reaction (PCR)
      • 6.6.8.2.1. Polymerase Chain Reaction (PCR) market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8.3. Next-Generation Sequencing (NGS)
      • 6.6.8.3.1. Next-Generation Sequencing (NGS) market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8.4. Others
      • 6.6.8.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Other processes
  • 6.7.1. Other processes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Bioanalytical Testing Services Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Bioanalytical Testing Services Market; End Use Movement Analysis
• 7.3. Bioanalytical Testing Services Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Pharma & BioPharma Companies
  • 7.4.1. Pharma & biopharma companies market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. CDMO
  • 7.5.1. CDMO market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. CRO
  • 7.6.1. CRO market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
• 8.3. North America
  • 8.3.1. North America bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory framework
    • 8.3.2.4. U.S. bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory framework
    • 8.3.3.4. Canada bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory framework
    • 8.3.4.4. Mexico bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Germany bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. UK
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. UK bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. France bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Competitive scenario
    • 8.4.5.3. Regulatory framework
    • 8.4.5.4. Italy bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Competitive scenario
    • 8.4.6.3. Regulatory framework
    • 8.4.6.4. Spain bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Netherlands
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Competitive scenario
    • 8.4.7.3. Regulatory framework
    • 8.4.7.4. Netherlands bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.8. Switzerland
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Competitive scenario
    • 8.4.8.3. Regulatory framework
    • 8.4.8.4. Switzerland bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.9. Denmark
    • 8.4.9.1. Key country dynamics
    • 8.4.9.2. Competitive scenario
    • 8.4.9.3. Regulatory framework
    • 8.4.9.4. Denmark bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.10. Sweden
    • 8.4.10.1. Key country dynamics
    • 8.4.10.2. Competitive scenario
    • 8.4.10.3. Regulatory framework
    • 8.4.10.4. Sweden bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.11. Norway
    • 8.4.11.1. Key country dynamics
    • 8.4.11.2. Competitive scenario
    • 8.4.11.3. Regulatory framework
    • 8.4.11.4. Norway bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Japan bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. China bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. India bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. South Korea bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Australia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Competitive scenario
    • 8.5.7.3. Regulatory framework
    • 8.5.7.4. Thailand bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Indonesia
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Competitive scenario
    • 8.5.8.3. Regulatory framework
    • 8.5.8.4. Indonesia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Malaysia
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Competitive scenario
    • 8.5.9.3. Regulatory framework
    • 8.5.9.4. Malaysia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.10. Singapore
    • 8.5.10.1. Key country dynamics
    • 8.5.10.2. Competitive scenario
    • 8.5.10.3. Regulatory framework
    • 8.5.10.4. Singapore bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.11. Taiwan
    • 8.5.11.1. Key country dynamics
    • 8.5.11.2. Competitive scenario
    • 8.5.11.3. Regulatory framework
    • 8.5.11.4. Taiwan bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Brazil bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Argentina bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. Colombia
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. Colombia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. South Africa bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Saudi Arabia bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. UAE bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Kuwait bioanalytical testing services market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Company Market Position Analysis, 2024
• 9.3. Company Profiles
  • 9.3.1. Thermo Fisher Scientific Inc
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Service benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. ICON Plc
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Service benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. Charles River Laboratories International
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Service benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. IQVIA Inc.
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Service benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Syneos Health
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Service benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. SGS SA
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Service benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Labcorp
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Service benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Intertek Group Plc
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Service benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Pace Analytical Services LLC
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Service benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Wuxi AppTec
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Service benchmarking
    • 9.3.10.4. Strategic initiatives

관련자료